SecBot SecBot

PRCT

PROCEPT BioRobotics Corp
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001588978 Robotics & Automation
$23.54 −0.26 (−1.09%)
Nov 16 4:00 PM ET · prev $23.80
Market cap
$1.4B
Small cap
Consensus
Buy
48% Buy or better · 21 analysts
Median target
$23.00
−2% · range $16.00–30.00
1 year
−19.1%
from $29.08 · Nov 17
30 days
+28.8%
from $18.28
52-week range
$16.69–36.10
−35% from high · low Jul 24
Avg volume 20D
1.32M
shares / day
Short interest
7.86M
≈13.7% of shares · +4.8%
Days to cover
9.0
at average volume
Insider net
+$9.6M
2 buyers · 4 sellers · since Mar 5
New fund stakes
0
Q3 2026 13F · 2 exits
Filing reports
16
analyzed by SecBot
SecBot read MIXED 5 reports · 90 days
Balance 0 bearish · 0 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 5/5

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBULLISH

    2 insiders bought $10.3M at an average $24.28. 4 insiders sold $716.7K.

  • InstitutionsBULLISH

    Q3 2026: 28 added (0 new), 16 trimmed or exited.

  • AnalystsBULLISH

    10 of 21 rate it Buy or better. Median target $23.00 (−2%).

  • EstimatesRISING

    Current-quarter EPS estimate −$0.254 → −$0.227 over 90 days. 2 up, 0 down in 30 days.

  • Short sellersSTEADY

    Short interest +4.8% to 7.86M shares. 9.0 days to cover, ≈13.7% of shares.

  • TrendUPTREND

    21% above its 50-day average.

Who's buying

13F· Q3 2026
0
new positions
2
exits
FundMoveSharesValue
JPMORGAN CHASE & CODOUBLED1,905,694$34.8M
BAILLIE GIFFORD & COADD1,203,791$21.9M
MORGAN STANLEYADD968,614$17.6M
FEDERATED HERMES, INC.TRIM845,204$15.4M
HRT FINANCIAL LPDOUBLED719,935$13.1M
BNP PARIBAS FINANCIAL MARKETSADD581,714$10.6M
BARCLAYS PLCADD266,458$4.9M
UBS Group AGTRIM255,475$4.7M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

21 analysts
Buy 48% rate it Buy or better
Strong Buy3Buy7Hold10Sell1Strong Sell0
12-month targets · 12 analysts

Price is inside the target range. Median implies −2%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 6, 2026Truist Securities
MAINTAIN
MAINTAINHold
Nov 5, 2026UBS
MAINTAIN
MAINTAINNeutral
Nov 5, 2026Leerink Partners
MAINTAIN
MAINTAINMarket Perform
Oct 7, 2026Barclays
INITIATE
INITIATEOverweight
Aug 5, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Aug 5, 2026Piper Sandler
MAINTAIN
MAINTAINOverweight

Insider ledger

Form 4
$10.3M
bought · 2 insiders
$716.7K
sold · 4 insiders
−3.0%
vs their $24.28 cost
DateInsiderTypeValue
Nov 6, 2026
Sharma Pooja
Chief Strat/Marketing Officer
Nov 6, 2026
SELL$92.9K
Oct 2, 2026
Mack Michael
Director
Oct 2, 2026
AWARD12,191 sh
Oct 2, 2026
Mack Michael
Director
Oct 2, 2026
AWARD7,727 sh
Sep 9, 2026
Waters Kevin
EVP, CFO
Sep 9, 2026
SELL$7.8K
Sep 9, 2026
Nouri Alaleh
EVP, CLO, CORP. SEC.
Sep 9, 2026
SELL$6.2K
Sep 9, 2026
Templin Barry L
EVP, Chief Technology Officer
Sep 9, 2026
SELL$7.8K
Aug 13, 2026
Waters Kevin
EVP, CFO
Aug 13, 2026
AWARD40,851 sh
Aug 13, 2026
Templin Barry L
EVP, Chief Technology Officer
Aug 13, 2026
AWARD26,246 sh

Earnings setup

Estimates
−$0.23
EPS estimate, this quarter
+11%
estimate change, 90 days
2↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.23-$0.28–-$0.14+10.9%$119.9M
Next Q-$0.43-$0.52–-$0.34-17.2%$104.6M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

6 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
7,858,235
shares short
+4.8%
vs prior settlement
9.0
days to cover
≈13.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 6, 2026 SEC
Pooja Sharma, an officer of PROCEPT BioRobotics, filed a Form 144 notice of intent to sell 4,710 shares of common…
144 · Impact 2/10
Nov 6, 2026 Insider
Sharma Pooja sold 4,710 shares
Chief Strat/Marketing Officer @ $19.71 ($92.9K)
Nov 4, 2026 SEC
The company reaffirmed its full-year 2026 revenue guidance of $390M-$410M and its adjusted EBITDA loss guidance of…
8-K · Impact 5/10
Nov 4, 2026 Earnings result
PRCT Q3 2026 Earnings: EPS $-0.46 (-16.5% vs est)
Oct 30, 2026 SEC
Vanguard Capital Management LLC filed an amended Schedule 13G reporting a 4.96% passive stake in PROCEPT BioRobotics…
SC 13G/A · Impact 2/10
Oct 2, 2026 Insider
Mack Michael was granted 12,191 shares
Director
Oct 2, 2026 Insider
Mack Michael was granted 7,727 shares
Director
Sep 30, 2026 Inst.
JPMORGAN CHASE & CO · DOUBLED
1,905,694 shares ($34.8M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 4, 2026
Earnings result
PRCT Q3 2026 Earnings: EPS $-0.46 (-16.5% vs est)
Oct 1, 2026
Press release
PROCEPT BioRobotics (NASDAQ: PRCT) Investors: Securities Class Action Filed; Shareholders Should Contact Shareholders Foundation
SAN DIEGO, Oct. 1, 2026 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit has been filed concerning certain investors in…
Sep 22, 2026
Press release
PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PRCT
NEW YORK, Sept. 22, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation…
Sep 21, 2026
Press release
PRCT FINAL DEADLINE ALERT: PROCEPT BioRobotics Corporation Investors Alerted to September 22, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit
SAN FRANCISCO, Sept. 21, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT)…
Sep 18, 2026
Press release
TUESDAY PRCT INVESTOR DEADLINE: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action Lawsuit
SAN DIEGO, Sept. 18, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of PROCEPT BioRobotics Corporation (NASDAQ…

SecBot reports

16 filings · 5 bullish · 0 bearish · 1 mixed · 10 neutral
All PRCT filing & press-release reports (16)